NEW YORK – What articles gained the most interest from GenomeWeb readers last week? Here are the top five:
1. Sema4 Cuts 13 Percent of Workforce, Exits Somatic Tumor Testing as Founder Schadt Departs
2. Illumina Lowers 2022 Guidance, Braces for Fines from European Commission
3. Genapsys Founders Lose Bid to Dismiss Bankruptcy Case
4. Eurobio Scientific to Acquire GenDx for €135M in Cash
5. Polygenic Risk Scores Can Differ for Same Disease in Individuals, Hampering Clinical Implementation